Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting prostate cancer behavior using transcript profiles.

Peter S Nelson1

  • 1Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. pnelson@fhcrc.org

The Journal of Urology
|November 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer.

The Journal of clinical investigation·2026
Same author

Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer.

Neoplasia (New York, N.Y.)·2026
Same author

Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

Molecular cancer research : MCR·2026
Same author

Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer.

NPJ precision oncology·2026
Same author

Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancer.

The Journal of clinical investigation·2026
Same author

PSMA PET/CT-derived Tumor Volume for Predicting Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617.

Radiology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
Same journal

With great cost comes great responsibility: who will own the rising costs of bladder cancer care?

The Journal of urology·2026
See all related articles

Gene expression profiling using microarrays can stratify prostate cancer into risk categories. This approach offers molecular insights into tumor behavior for improved treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Prostate cancer exhibits diverse clinical outcomes, necessitating accurate prognostication for optimal treatment.
  • Accurate disease status estimation is crucial for tailoring treatments and minimizing patient morbidities.
  • Emerging gene profiling technologies offer novel insights into tumor behavior and progression.

Purpose of the Study:

  • To review the application of microarray-based transcript expression profiling for stratifying human cancers into risk categories.
  • To highlight the use of gene expression profiles in predicting prostate cancer outcomes.
  • To discuss the potential of molecular profiling in cancer risk stratification.

Main Methods:

  • A comprehensive literature review of MEDLINE-reported studies on gene expression profiling in malignant diseases.

Related Experiment Videos

  • Emphasis on studies developing predictive models for prostate cancer outcomes using gene expression data.
  • Analysis of microarray-based transcript expression profiling techniques.

    • Main Results:

    • Gene expression alterations identified by microarrays correlate with outcomes in prostate and other cancers.
    • Developed prediction models stratify cancers into prognostic categories based on relapse rates and therapy response.
    • Microarray analysis provides quantitative and qualitative profiling of expressed genes in neoplastic tissues.

    Conclusions:

    • Gene expression profiles present molecular determinants for correlating with clinical outcomes.
    • Prospective validation and assessment of intratumor heterogeneity are needed for clinical utility.
    • Future research should integrate host factors like immune response and hormonal milieu for robust predictive models.